Hangzhou AGS MedTech Co. Ltd. A (SHG:688581) — Market Cap & Net Worth
Market Cap & Net Worth: Hangzhou AGS MedTech Co. Ltd. A (688581)
Hangzhou AGS MedTech Co. Ltd. A (SHG:688581) has a market capitalization of $719.37 Million (CN¥4.92 Billion) as of May 2, 2026. Listed on the SHG stock exchange, this China-based company holds position #10698 globally and #3145 in its home market, demonstrating a 7.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hangzhou AGS MedTech Co. Ltd. A's stock price CN¥60.60 by its total outstanding shares 81122079 (81.12 Million). Review Hangzhou AGS MedTech Co. Ltd. A debt and liabilities to assess the company's total debt and financial obligations.
Hangzhou AGS MedTech Co. Ltd. A Market Cap History: 2023 to 2026
Hangzhou AGS MedTech Co. Ltd. A's market capitalization history from 2023 to 2026. Data shows change from $1.03 Billion to $719.37 Million (-11.07% CAGR).
Hangzhou AGS MedTech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hangzhou AGS MedTech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.11x
Hangzhou AGS MedTech Co. Ltd. A's market cap is 1.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.42x
Hangzhou AGS MedTech Co. Ltd. A's market cap is 2.42 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $1.03 Billion | $508.75 Million | $217.24 Million | 2.03x | 4.74x |
| 2024 | $708.56 Million | $636.63 Million | $293.39 Million | 1.11x | 2.42x |
Competitor Companies of 688581 by Market Capitalization
Companies near Hangzhou AGS MedTech Co. Ltd. A in the global market cap rankings as of May 2, 2026.
Key companies related to Hangzhou AGS MedTech Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Hangzhou AGS MedTech Co. Ltd. A Historical Marketcap From 2023 to 2026
Between 2023 and today, Hangzhou AGS MedTech Co. Ltd. A's market cap moved from $1.03 Billion to $ 719.37 Million, with a yearly change of -11.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥719.37 Million | +3.36% |
| 2025 | CN¥695.98 Million | -1.78% |
| 2024 | CN¥708.56 Million | -31.23% |
| 2023 | CN¥1.03 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Hangzhou AGS MedTech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $719.37 Million USD |
| MoneyControl | $719.37 Million USD |
| MarketWatch | $719.37 Million USD |
| marketcap.company | $719.37 Million USD |
| Reuters | $719.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hangzhou AGS MedTech Co. Ltd. A
Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more